Therapeutic strategies for ovarian cancer: AMHR2-RNA aptamer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10633663
APP PUB NO 20190071674A1
SERIAL NO

16119258

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Various aspects of the invention relate to aptamers that specifically bind Müllerian inhibitory substance II receptor (MISIIR).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF CINCINNATI2900 READING ROAD SUITE 260 CINCINNATI OH 45206

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ho, Shuk-mei Cincinnati, US 5 1
Tarapore, Pheruza Cincinnati, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 28, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00